Condition: Brain Tumor, Primary · Brain Tumor - Metastatic · Sponsor: Pietro Mortini, MD, Prof.
The goal of this observational study is to characterize the circulating leukocyte profile and the immune T cells distribution within the tumor in patients with malignant brain tumors and to correlate these findings with the oncological outcome. Participants will be subjected to blood sampling before surgery and for 12 months of follow-up. Additional sampling and analysis will be performed on tumor samples.
This description comes directly from the study's public registry record.
Laura Sincinelli · 0226435568 · sincinelli.laura@hsr.it
Always discuss trial participation with your own doctor first.
| IRCCS San Raffaele Scientific Institute | Milan, Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05831631